Incidence of bevacizumab (BE) related toxicities: Association of hypertension (HTN) and proteinuria (PTN), a BE toxicity syndrome (BETS)
| Autor: | Linda D. Bosserman, R. C. Horns, G. Upadhyaya, M. J. Vakil, Christina Yeon, Cary A. Presant, B. Ebrahimi, C. L. Martel |
|---|---|
| Rok vydání: | 2005 |
| Předmět: |
Oncology
Cancer Research medicine.medical_specialty Chemotherapy Proteinuria Bevacizumab medicine.drug_class Colorectal cancer business.industry Incidence (epidemiology) medicine.medical_treatment Pharmacology Monoclonal antibody medicine.disease humanities Internal medicine Toxicity medicine In patient medicine.symptom business medicine.drug |
| Zdroj: | Journal of Clinical Oncology. 23:8062-8062 |
| ISSN: | 1527-7755 0732-183X |
| DOI: | 10.1200/jco.2005.23.16_suppl.8062 |
| Popis: | 8062 Background: BE, a monoclonal antibody that inhibits VEGF, prolongs survival in patients (pts) with metastatic colorectal cancer treated with 5FU chemotherapy. However, BE is associated with HT... |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|